SHANIQUA SIMS: Open Payments
NPI 1548772544 · FLOWERY BRANCH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 53 payments from 20 companies in 2025. Trend: 2023 $765 · 2024 $1,125 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $255 |
| Lilly USA, LLC | 7 | $219 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Exact Sciences Corporation | 3 | $47 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| Eisai Inc. | 2 | $46 |
| Amgen Inc. | 3 | $46 |
| ABBVIE INC. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Edwards Lifesciences Corporation | 1 | $29 |
Products named: Wegovy, ZEPBOUND, MOUNJARO, Ozempic, Cologuard Collection Kit, CONTRAVE, Leqembi, OTEZLA.
Industry payments across GA — which companies pay providers there.
